EarningsQ3 2021 Earnings Report

Tandem Diabetes Care (TNDM) Q3 2021 Earnings Report

0 Followers

MX:TNDM Q3 2021 EPS Results

Actual EPS$1.66

Consensus EPS$1.05

Beat/MissBeat by +$0.61

One Year Ago EPS-$2.77

Actual Revenue$3.32B

Expected Revenue$3.17B

Beat/MissBeat by +$152.64M

YoY Revenue Growth+45.33%

QuarterQ3 2021

Date11/03/2021

TimeAfter Close

Conference CallWednesday, November 3, 2021

MX:TNDM Upcoming Earnings

Tandem Diabetes Care's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-4.53 / -	-5.785	―
Aug 06, 2026	2026 (Q2)	-5.93 / -5.67	-8.908	36.31% (+3.23)
May 07, 2026	2026 (Q1)	-8.21 / -5.51	-12.364	55.46% (+6.86)
Feb 19, 2026	2025 (Q4)	-1.72 / -0.17	0.185	-190.00% (-0.35)
Nov 06, 2025	2025 (Q3)	-6.08 / -5.78	-6.469	10.57% (+0.68)
Aug 06, 2025	2025 (Q2)	-7.37 / -8.91	-8.686	-2.55% (-0.22)
Apr 30, 2025	2025 (Q1)	-11.18 / -12.36	-12.013	-2.92% (-0.35)
Feb 26, 2025	2024 (Q4)	-3.77 / 0.18	-8.502	102.17% (+8.69)
Nov 06, 2024	2024 (Q3)	-7.45 / -6.47	-9.426	31.37% (+2.96)
Aug 01, 2024	2024 (Q2)	-9.89 / -8.69	-10.165	14.55% (+1.48)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed